HEALTHCARE

HOME » BUSINESS » HEALTHCARE » Page 2
» 2019-03-27

Pharmaceutical major Strides Pharma Science Ltd said it received approval from the United States  Food and Administration for its greenfield oral medication facility in Singapore, giving a boost to the […]

» 2019-03-26

Pharmaceutical manufacturer Laurus Labs said that its has entered into a strategic partnership agreement with United Nations’ The Global Fund to sell a generic version of Viiv Healthcare’s dolutegravir (DTG) […]

» 2019-03-26

Pharmaceutical major Lupin said that YL Biologics Limited, its newly formed joint venture with Japanese pharma company Yoshindo Inc has received approval from the Pharmaceutical and Medical Devices Agency (PMDA) […]

» 2019-03-25

Pharmaceutical major Lupin said that it has received approval from the United States Food and Drug Administration for the sales of a generic equivalent of Pfizer Inc’s Viagra tablets. Sildenafil […]

» 2019-03-22

Pharmaceutical manufacturer Zydus Cadila said it received final approval from the United States Food and Drug Administration for sales of a generic version of Sunovion Pharmaceuticals’ Latuda tablets. Lurasidone tablets […]

» 2019-03-22

Pharmaceutical manufacturer Caplin Point Laboratories Ltd said it received approval from the US Food and Drug Administration for sales of a generic equivalent of West-Ward Pharmaceuticals’ Robinul drug. Glycopyrrolate is […]

» 2019-03-22

Pharmaceutical major Lupin said that it has launched the generic equivalent of AbbVie Inc’s Synthroid tablets. The Levothyroxine Sodium tablets is used to treat thyroid hormone deficiency, including the severe […]

» 2019-03-22

Gujarat-headquartered Alembic Pharmaceuticals said that it received approval from the United States Food and Drug Administration for sales of a generic version of Mylan’s Optivar eye-drops. Azelastine Hydrochloride Solution eye […]

» 2019-03-19

Pharmaceutical manufacturer Zydus Cadila said that it received final approval from the United States Food and Drug Administration for the sale of a generic version of Valeant’s Zovirax ointment. Acyclovir, […]

» 2019-03-15

Mumbai-based pharmaceutical firm Glenmark Pharmaceuticals said it received final approval from the US Food and Administration (USFDA) for the sale of a generic version of Valeant Bermuda’s acne treatment, BenzaClin. […]

» 2019-03-14

Pharmaceutical manufacturer Zydus Cadila said it received tentative approval from the US Food and Administration for the sales of of Sitagliptin and Metformin oral diabetes tablets that help control blood […]

» 2019-03-13

Pharmaceutical company Unichem Laboratories said it received final approval from the United States Food and Drug Administration for the sale of a generic version of Casper Pharma’s Zyloprim tablets. Allopurinol […]

» 2019-03-13

Pharmaceutical manufacturer Zydus Cadila said it received final approval from the US Food and Drug Administration for the sales of Potassium Chloride extended-release tablets for the treatment of various diseases […]

» 2019-03-12

Even as US-based Amgen Inc mounts a legal challenge, Piramal Enterprises said its US partner Slate Run Pharmaceuticals has launched the generic equivalent of Amgen’s hyperthyroidism drug Sensipar. Amgen challenged […]

» 2019-03-12

Pharmaceutical manufacturer Zydus Cadila said it received final approval from the US Food and Drug Administration to launch Atenolol and Chlorthalidone tablets to treat hypertension and chest pain. The company […]

» 2019-03-11

Pharmaceutical manufacturer Laurus labs said it received final approval from the US Food and Drug Administration to launch a generic equivalent of Concordia Pharmaceuticals’ malaria drug Plaquenil. Hydroxychloroquine is also […]

» 2019-03-05

Pharmaceutical major Lupin and partner Natco Pharma received approval from the US Food and Drug Administration (FDA) to sell a generic equivalent of Novartis Pharmaceuticals’ Gleevec cancer tablets in the […]

» 2019-03-04

Glenmark Pharmaceuticals, a pharmaceutical company headquartered in Mumbai, reported progress in a proof-of-concept study of GBR 830, being studied as a treatment for atopic dermatitis, commonly known as eczema. The […]

» 2019-02-28

Pharmaceuticals manufacturer Lupin said it has launched an exclusive generic version of Gilead Sciences’ heart drug Ranexa in the US. Ranolazine ER, to be sold in 500mg and 1000mg tablets, […]

» 2019-02-06

Strides Pharma said the US Food & Drug Administration completed an inspection of the company’s primary manufacturing facility in India with zero adverse observations. The company’s formulations facility at KRSG […]

Sign up to get the latest Pharma-related news delivered via email:

Don't forget to click on the activation link we send to your email